Pharmaroth Labs Stock Analysis
| ROTH Stock | USD 0.0001 0.00 0.00% |
Pharmaroth Labs' financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Pharmaroth Labs' financial risk is the risk to Pharmaroth Labs stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Pharmaroth Labs' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Pharmaroth Labs is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Pharmaroth Labs to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Pharmaroth Labs is said to be less leveraged. If creditors hold a majority of Pharmaroth Labs' assets, the Company is said to be highly leveraged.
Pharmaroth Labs is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Pharmaroth Labs stock analysis is to determine its intrinsic value, which is an estimate of what Pharmaroth Labs is worth, separate from its market price. There are two main types of Pharmaroth Labs' stock analysis: fundamental analysis and technical analysis.
The Pharmaroth Labs stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Pharmaroth Labs' ongoing operational relationships across important fundamental and technical indicators.
Pharmaroth | Build AI portfolio with Pharmaroth Stock |
Pharmaroth Stock Analysis Notes
The company had not issued any dividends in recent years. Pharmaroth Labs had 5:1 split on the 1st of June 2010. PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada. Pharmaroth Labs is traded on OTC Exchange in the United States. To find out more about Pharmaroth Labs contact Luis Lopez at 212-541-6222 or learn more at https://www.feroindustries.com.Pharmaroth Labs Investment Alerts
| Pharmaroth Labs generated a negative expected return over the last 90 days | |
| Pharmaroth Labs has some characteristics of a very speculative penny stock | |
| Pharmaroth Labs has a very high chance of going through financial distress in the upcoming years | |
| Pharmaroth Labs currently holds 853.53 K in liabilities. Pharmaroth Labs has a current ratio of 0.24, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Pharmaroth Labs' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 181.56 K. Net Loss for the year was (91.52 K) with profit before overhead, payroll, taxes, and interest of 80.48 K. | |
| Pharmaroth Labs currently holds about 33 in cash with (17.6 K) of positive cash flow from operations. | |
| Pharmaroth Labs has a frail financial position based on the latest SEC disclosures |
Pharmaroth Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 14.94 K.Pharmaroth Profitablity
The company has Profit Margin (PM) of (2.79) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.49) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.49.Technical Drivers
Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pharmaroth Labs, as well as the relationship between them.Pharmaroth Labs Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Moving Average is predictive technique used to analyze Pharmaroth Labs price data points by creating a series of averages of different subsets of Pharmaroth Labs entire price series.
Pharmaroth Labs Outstanding Bonds
Pharmaroth Labs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pharmaroth Labs uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pharmaroth bonds can be classified according to their maturity, which is the date when Pharmaroth Labs has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| PHARMACIA P 66 Corp BondUS71713UAW27 | View | |
| PHARMACIA P 675 Corp BondUS71713UAT97 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Pharmaroth Labs Bond Ratings
Pharmaroth Labs financial ratings play a critical role in determining how much Pharmaroth Labs have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Pharmaroth Labs' borrowing costs.| Piotroski F Score | 2 | Frail | View |
| Beneish M Score | (4.16) | Unlikely Manipulator | View |
Pharmaroth Labs Debt to Cash Allocation
As Pharmaroth Labs follows its natural business cycle, the capital allocation decisions will not magically go away. Pharmaroth Labs' decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Pharmaroth Labs currently holds 853.53 K in liabilities. Pharmaroth Labs has a current ratio of 0.24, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Pharmaroth Labs' use of debt, we should always consider it together with its cash and equity.Pharmaroth Labs Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Pharmaroth Labs' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Pharmaroth Labs, which in turn will lower the firm's financial flexibility.Pharmaroth Labs Corporate Bonds Issued
Most Pharmaroth bonds can be classified according to their maturity, which is the date when Pharmaroth Labs has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
About Pharmaroth Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Pharmaroth Labs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pharmaroth shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pharmaroth Labs. By using and applying Pharmaroth Stock analysis, traders can create a robust methodology for identifying Pharmaroth entry and exit points for their positions.
PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada. Pharmaroth Labs is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Pharmaroth Labs to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Complementary Tools for Pharmaroth Stock analysis
When running Pharmaroth Labs' price analysis, check to measure Pharmaroth Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmaroth Labs is operating at the current time. Most of Pharmaroth Labs' value examination focuses on studying past and present price action to predict the probability of Pharmaroth Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmaroth Labs' price. Additionally, you may evaluate how the addition of Pharmaroth Labs to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |